This start-up is focused on the development of medical devices used in fertility treatments. Their technology is based on micro membranes and microfluidic devices.
Current sperm selection methods affect sperm DNA and therefore its ability to generate healthy embryos. They also require complex equipment and facilities.
Selectivity is developing a microfluidic sperm selection device that exceeds the performance of existing processes, simplifying them and minimizing their impact on the DNA of selected cells, thus making treatments safer and universally accessible.